Quarterly report (Form 10-Q)
Boston Scientific 10-Q for Quarter ended Sep 30, 2026
Filing excerpt
On February 26, 2026, we entered into a new $3.000 billion revolving credit agreement (the 2026 Revolving Credit Agreement) with a global syndicate of commercial banks and terminated our previous revolving credit agreement (the 2021 Revolving Credit Agreement).